You are here
CERID Bibliography
Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1. AIDS. 2013 ;27(1):135-7.
. Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection. J Virol. 2012 ;86(2):947-60.
HIV shedding in the oral cavity: an assessment of HIV type, immunovirologic, demographic and oral factors. Sex Transm Infect. 2012 ;88(1):45-50.
. Three main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimens. PLoS One. 2012 ;7(9):e45372.
. Trends of HIV-1, HIV-2 and dual infection in women attending outpatient clinics in Senegal, 1990-2009. Int J STD AIDS. 2012 ;23(10):710-6.
. Validation for clinical use of a novel HIV-2 plasma RNA viral load assay using the Abbott m2000 platform. J Clin Virol. 2012 ;55(2):128-33.
. Association between peripheral γδ T-cell profile and disease progression in individuals infected with HIV-1 or HIV-2 in West Africa. J Acquir Immune Defic Syndr. 2011 ;57(2):92-100.
. HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa. PLoS One. 2011 ;6(7):e22204.
. Antiretroviral drug resistance in HIV-2: three amino acid changes are sufficient for classwide nucleoside analogue resistance. J Infect Dis. 2009 ;199(9):1323-6.
. A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. AIDS. 2008 ;22(16):2069-72; discussion 2073-4.
. Differences in proviral DNA load between HIV-1-infected and HIV-2-infected patients. AIDS. 2008 ;22(11):1379-80.
. HIV type 2 protease, reverse transcriptase, and envelope viral variation in the PBMC and genital tract of ARV-naive women in Senegal. AIDS Res Hum Retroviruses. 2008 ;24(6):857-64.
. Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro. Antimicrob Agents Chemother. 2008 ;52(1):329-32.
. . Presenting plasma HIV RNA level and rate of CD4 T-cell decline. JAMA. 2007 ;297(8):805; author reply 806-7.
. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection. J Virol. 2007 ;81(17):9061-71.
.
Characteristics and presenting complaints of outpatients with undiagnosed HIV infection: potential utility in selecting subjects for HIV testing. J Acquir Immune Defic Syndr. 2004 ;37(4):1520-8.
. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal. J Virol. 2004 ;78(24):13934-42.
. No evidence for recombination between HIV type 1 and HIV type 2 within the envelope region in dually seropositive individuals from Senegal. AIDS Res Hum Retroviruses. 2004 ;20(9):958-63.
. Molecular epidemiology of dual HIV-1/HIV-2 seropositive adults from Senegal, West Africa. AIDS Res Hum Retroviruses. 2003 ;19(7):575-84.
. Re: Follow-up study of intrahost HIV type 2 variability reveals discontinuous evolution of C2V3 sequences. AIDS Res Hum Retroviruses. 2001 ;17(16):1563-5, 1567.
.